BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/28/2020 8:04:30 AM | Browse: 1042 | Download: 1738
 |
Received |
|
2019-12-31 10:36 |
|
Peer-Review Started |
|
2019-12-31 10:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-01-13 17:25 |
|
Revised |
|
2020-03-26 12:25 |
|
Second Decision |
|
2020-04-03 13:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-04-04 02:52 |
|
Articles in Press |
|
2020-04-04 02:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-04-06 02:22 |
|
Typeset the Manuscript |
|
2020-04-26 01:35 |
|
Publish the Manuscript Online |
|
2020-04-28 08:04 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu and Yong-Jian Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Guangzhou General Science and Technology Project of Health and Family Planning |
20191A011001 |
| Guangzhou Planned Project of Science and Technology |
201904010132 |
|
| Corresponding Author |
Yong-Jian Zhou, MD, PhD, Professor, Department of Gastroenterology and Hepatology, Guangzhou Institute of Digestive Disease, Guangzhou Medical University, No. 1, Panfu Road, Guangzhou 510180, Guangdong Province, China. yjzhou@gzhmu.edu.cn |
| Key Words |
Non-alcoholic fatty liver disease; Gut microbiota; Probiotics; Prebiotics; Fecal microbiota transplantation; Metabolites |
| Core Tip |
Non-alcoholic fatty liver disease is a highly prevalent metabolic disease worldwide. In this review, we have summarized the most recent advances in gut microbiota-targeted therapies against non-alcoholic fatty liver disease, including antibiotics, probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and the gut microbiota-derived components and metabolites. |
| Publish Date |
2020-04-28 08:04 |
| Citation |
Chen HT, Huang HL, Li YQ, Xu HM, Zhou YJ. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World J Gastroenterol 2020; 26(16): 1901-1911 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i16/1901.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i16.1901 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
